Viveve Medical, Inc.

NASDAQ:VIVE

$0.0002 USD

$0.0 (-86.67%)

Volume
56.88K
Average Volume
11.44K
Market Capitalization
$2.14K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
$
Year High
$1.00
Year Low
$0.00
Payout Ratio
$-0.21
Current Ratio
$4.91

Industry, Sector & symbol

Stock Exchange NASDAQ Capital Market
CEO Ms. Deborah Ann Jorn M.B.A.
Industry Medical Devices
Sector Healthcare
Current Symbol VIVE
CUSIP 92852W303
CIK 0000879682
Web https://www.viveve.com
Phone 720 696 8100
Currency USD
Employees 47
Country US

Liquidity

Debt-to-Equity Ratio 0.36
Payout Ratio -0.21
Current Ratio 4.91
Quick Ratio 4.35
Cash Ratio 4.23

Sales & Book Value

Annual Sales $6.43M
Price / Sales 0.00
Cash Flow -1.32
Price / Cash Flow 0.00
Price / Book 0.00

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Buy
Rating Score(0-5) 4
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-2.26
Trailing P/E Ratio 0.00
PEG Ratio 0.00
P/E Growth 0.00
Net Income $-22.82M
Net Margin -355.18%
Pretax Margin -338.80%
Return on Equity -207.11%
Return on Assets -88.08%

Financials Score

AltmanZ Score -35.08
Piotroski Score 4.00
Working Capital -1.23M
Total Assets 12.15M
Ebit -21.14M
Market Cap 2.14K
Total Liabilities 10.97M

Poll Results

About Viveve Medical, Inc. (NASDAQ:VIVE) Stock

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. ...

Why Is Viveve Medical (VIVE) Stock Down 69% Today?

2023-01-17 08:43:42

Viveve Medical (NASDAQ: VIVE ) stock is falling hard on Tuesday after releasing results from the company's latest clinical trial. That trial covers the use of the Viveve treatment for women suffering from stress urinary incontinence.

Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript

2022-11-10 21:25:04

Viveve Medical, Inc. (NASDAQ:VIVE ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - CEO Jim Robbins - SVP, Finance and Administration Operator Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call.

Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

2022-10-27 08:28:00

ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.

Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript

2022-08-11 18:38:04

Viveve Medical, Inc. (NASDAQ:VIVE ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - SVP, Finance and Administration Scott Durbin - CEO Conference Call Participants Operator Good afternoon, and welcome to the Viveve Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please note, this event is being recorded.

Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022

2022-07-28 16:28:00

ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.

Frequently Asked Questions

What is the current Viveve Medical, Inc. (VIVE) stock price?

Viveve Medical, Inc.(NASDAQ:VIVE) stock price is $0.0002 in the last trading session. During the trading session, VIVE stock reached the peak price of $6 while $1.0E was the lowest point it dropped to. The percentage change in VIVE stock occurred in the recent session was --86.67% while the dollar amount for the price change in VIVE stock was -$-0.0.

VIVE's industry and sector of operation?

The NASDAQ listed VIVE is part of Medical Devices industry that operates in the broader Healthcare sector.

Who are the executives of VIVE?

Ms. Jeannie Swindle | Senior Director of Corporate Communications
Ms. Suzon D. Lommel | Senior Vice President of Regulatory & Quality Affairs
Mr. Jeff Sinclair | Vice President of International Sales
Ms. Lori McMillan | Vice President of Human Resources
Mr. Gary Kaiser | Vice President of Global Marketing

How many employees does VIVE have?

Number of VIVE employees currently stands at 47. VIVE operates from Building B, Englewood, CO 80112, US.

Link for VIVE official website?

Official Website of VIVE is: https://www.viveve.com

How do I contact VIVE?

VIVE could be contacted at phone #720 696 8100 and can also be accessed through its website. VIVE operates from Building B, Englewood, CO 80112, US.

How many shares of VIVE are traded daily?

The average number of VIVE shares traded daily for last 3 months was 11.44K.

What is the market cap of VIVE currently?

The market value of VIVE currently stands at $2.14K with its latest stock price at $0.0002